MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Physicians Realty Trust Company Profile (NYSE:DOC)

Consensus Ratings for Physicians Realty Trust (NYSE:DOC) (?)
Ratings Breakdown: 9 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.71 (23.26% upside)

Analysts' Ratings History for Physicians Realty Trust (NYSE:DOC)
Show:
DateFirmActionRatingPrice TargetActions
8/27/2015JMP SecuritiesLower Price TargetMarket Outperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Canaccord GenuityReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015BMO Capital MarketsLower Price TargetOutperform$20.00 -> $19.20View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015Canaccord GenuityReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2015OppenheimerReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2015Canaccord GenuityInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2015BMO Capital MarketsInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015RBC CapitalInitiated CoverageOutperform$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/16/2015OppenheimerBoost Price Target$16.75 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2015WunderlichBoost Price TargetBuy$16.25 -> $17.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2014Raymond JamesInitiated CoverageOutperform$15.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/22/2014Compass PointBoost Price TargetBuy$16.50 -> $17.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014WunderlichBoost Price TargetBuy$15.50 -> $16.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014Compass PointBoost Price Target$16.00 -> $16.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014OppenheimerBoost Price TargetOutperform$14.00 -> $15.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2014MLV & Co.Initiated CoverageBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014Bank of AmericaInitiated CoverageBuy$14.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/21/2014WunderlichBoost Price TargetBuy$14.75 -> $15.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2014WunderlichReiterated RatingBuy$14.00 -> $14.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2014KeyBancInitiated CoverageHold -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2014OppenheimerInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2014JMP SecuritiesInitiated CoverageOutperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2013Compass PointBoost Price TargetBuy$13.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2013Hilliard LyonsInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2013Janney Montgomery ScottInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha